170 results on '"Witte, T."'
Search Results
2. The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis
3. Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome
4. Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
5. TMJ pathology: is it real?
6. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT
7. Foxp3+ regulatory T cells are expanded in severe atopic dermatitis patients
8. Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
9. Increased T-cell turnover is associated with spondyloarthritis in virally suppressed patients with HIV-1 infection
10. Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial
11. Bilateral leiomyoma in the testes of a horse
12. High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT
13. Allogeneic Hematopoietic Stem Cell Transplantation in Solid Organ Transplant Recipients: A Retrospective, Multicenter Study of the EBMT
14. Autoantibodies binding to ubiquitin-fold modifier-conjugating enzyme 1 (Ufc1) and pleckstrin homology domain containing, family G (with RhoGef domain) member 2 (Plekhg2) are associated with mycobacterial infections
15. Modulation of heme oxygenase-1 by metalloporphyrins increases anti-viral T cell responses
16. Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis
17. Pathogenetic role of glomerular CXCL13 expression in lupus nephritis
18. Influence of the IL17A locus in giant cell arteritis susceptibility
19. Autoantibodies against CD74 in spondyloarthritis
20. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis
21. Temporohyoid osteoarthropathy in the horse
22. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS FEASIBLE AFTER SOLID ORGAN TRANSPLANTATION: FINAL ANALYSIS BY THE EARLY COMPLICATIONS SUBCOMMITTEE OF THE COMPLICATIONS AND QUALITY OF LIFE WORKING PARTY, EBMT: PH-P351
23. THE REVISED IPSS (IPSS-R) AT TRANSPLANT PREDICTS OVERALL AND RELAPSE-FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN MDS/SAML: A RETROSPECTIVE ANALYSIS OF THE EBMT CHRONIC MALIGNANCIES WORKING PARTY: WP-O014
24. REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA: A COMPARISON OF TANDEM AUTO-ALLOGRAFT TO EARLY REDUCED INTENSITY ALLOGRAFT AS UPFRONT TRANSPLANT: AN EBMT ANALYSIS ON BEHALF OF THE PLASMA CELL DISORDERS: PH-O144
25. IMPACT OF CYTOGENETIC USING THE IPSS REVISED CYTOGENETIC CLASSIFICATION ON OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR MDS OR AML EVOLVING FROM MDS: A RETROSPECTIVE MULTICENTER STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF THE EBMT: PH-O012
26. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice: This article has been corrected since Online Publication and a corrigendum has also been published
27. Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation
28. Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
29. Three horses with bilateral sinonasal progressive haematomas not associated with the ethmoidal labyrinth
30. The German national registry for primary immunodeficiencies (PID)
31. In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patientʼs burden
32. Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation
33. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with < 10% BM blasts: a report from EBMT
34. Development and validation of an equine nerve block simulator to supplement practical skills training in undergraduate veterinary students
35. Outcome and prognostic factors in patients with mantle cell lymphoma relapsing after autologous stem cell transplantation: a retrospective study of the EBMT: O330
36. Prophylaxis and treatment of graft-versus-host disease: EBMT - ELN working group recommendations for a standardized practice: 296
37. Second allogeneic haematopoietic stem cell transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors: 196
38. Reduced versus standard conditioning in MDS/sAML: preliminary results of a prospective, randomized Phase III trial of Chronic Malignancies Working Party of the EBMT (RICMAC-Trial): 201
39. Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in multiple myeloma - update of the EBMT-NMAM2000 study at 96 months median follow-up: 197
40. Impact of graft-versus-host disease on relapse after allogeneic stem cell transplantation: an EBMT megafile study: 200
41. Allogeneic HSCT in patients with 17p- CLL: first results of a non-interventional prospective study: 199
42. Reduced-intensity conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation : a study by the European Group for Blood and Marrow Transplantation Chronic Malignancies Working Party: O156
43. Higher probability of survival in complete remission following tandem autologous/reduced-intensity allogeneic transplantation compared to autologous transplantation alone in the NMAM2000 multiple myeloma trial as estimated by multistate models: O158
44. Prospective analysis of prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by allogeneic haematopoietic stem cell transplantation: a study on behalf of the MDS subcommittee of the Chronic Malignancies Working Party of the EBM: O157
45. Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia
46. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings
47. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation
48. Incompetent cervix and pneumouterus in a maiden mare
49. Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis
50. The EBMT activity survey: 1990-2010
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.